<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2024-10-02" version="215" xmlns="http://uniprot.org/uniprot">
  <accession>Q13435</accession>
  <accession>A8K485</accession>
  <accession>B4DT19</accession>
  <accession>Q7L4T5</accession>
  <accession>Q7Z627</accession>
  <accession>Q969K1</accession>
  <accession>Q96CM6</accession>
  <accession>Q9BWD2</accession>
  <name>SF3B2_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Splicing factor 3B subunit 2</fullName>
    </recommendedName>
    <alternativeName>
      <fullName>Pre-mRNA-splicing factor SF3b 145 kDa subunit</fullName>
      <shortName>SF3b145</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>Spliceosome-associated protein 145</fullName>
      <shortName>SAP 145</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">SF3B2</name>
    <name type="synonym">SAP145</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <source>
      <tissue>Lymphoblast</tissue>
      <tissue>Peripheral blood</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <source>
      <tissue>Eye</tissue>
      <tissue>Kidney</tissue>
      <tissue>Lung</tissue>
      <tissue>Testis</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1996" name="Genes Dev." volume="10" first="233" last="243">
      <title>Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A.</title>
      <authorList>
        <person name="Gozani O."/>
        <person name="Feld R."/>
        <person name="Reed R."/>
      </authorList>
      <dbReference type="PubMed" id="8566756"/>
      <dbReference type="DOI" id="10.1101/gad.10.2.233"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 9-895</scope>
    <scope>PROTEIN SEQUENCE OF 174-182 AND 817-840</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="779" last="787">
      <title>Functional association of U2 snRNP with the ATP-independent spliceosomal complex E.</title>
      <authorList>
        <person name="Das R."/>
        <person name="Zhou Z."/>
        <person name="Reed R."/>
      </authorList>
      <dbReference type="PubMed" id="10882114"/>
      <dbReference type="DOI" id="10.1016/s1097-2765(00)80318-4"/>
    </citation>
    <scope>CHARACTERIZATION OF THE SPLICEOSOME</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2002" name="EMBO J." volume="21" first="4978" last="4988">
      <title>Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein.</title>
      <authorList>
        <person name="Will C.L."/>
        <person name="Urlaub H."/>
        <person name="Achsel T."/>
        <person name="Gentzel M."/>
        <person name="Wilm M."/>
        <person name="Luehrmann R."/>
      </authorList>
      <dbReference type="PubMed" id="12234937"/>
      <dbReference type="DOI" id="10.1093/emboj/cdf480"/>
    </citation>
    <scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2002" name="RNA" volume="8" first="426" last="439">
      <title>Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.</title>
      <authorList>
        <person name="Jurica M.S."/>
        <person name="Licklider L.J."/>
        <person name="Gygi S.P."/>
        <person name="Grigorieff N."/>
        <person name="Moore M.J."/>
      </authorList>
      <dbReference type="PubMed" id="11991638"/>
      <dbReference type="DOI" id="10.1017/s1355838202021088"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <scope>IDENTIFICATION IN THE SPLICEOSOMAL C COMPLEX</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2003" name="Science" volume="300" first="980" last="984">
      <title>Molecular architecture of the multiprotein splicing factor SF3b.</title>
      <authorList>
        <person name="Golas M.M."/>
        <person name="Sander B."/>
        <person name="Will C.L."/>
        <person name="Luhrmann R."/>
        <person name="Stark H."/>
      </authorList>
      <dbReference type="PubMed" id="12738865"/>
      <dbReference type="DOI" id="10.1126/science.1084155"/>
    </citation>
    <scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
    <scope>ELECTRON MICROSCOPY OF THE SF3B COMPLEX</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2004" name="RNA" volume="10" first="929" last="941">
      <title>The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.</title>
      <authorList>
        <person name="Will C.L."/>
        <person name="Schneider C."/>
        <person name="Hossbach M."/>
        <person name="Urlaub H."/>
        <person name="Rauhut R."/>
        <person name="Elbashir S."/>
        <person name="Tuschl T."/>
        <person name="Luehrmann R."/>
      </authorList>
      <dbReference type="PubMed" id="15146077"/>
      <dbReference type="DOI" id="10.1261/rna.7320604"/>
    </citation>
    <scope>IDENTIFICATION IN A COMPLEX WITH THE MINOR SPLICEOSOME</scope>
    <scope>FUNCTION</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 AND SER-436</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="8149" last="8158">
      <title>Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.</title>
      <authorList>
        <person name="Terada Y."/>
        <person name="Yasuda Y."/>
      </authorList>
      <dbReference type="PubMed" id="16923959"/>
      <dbReference type="DOI" id="10.1128/mcb.01170-06"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 VPR (MICROBIAL INFECTION)</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
      <title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
      <authorList>
        <person name="Matsuoka S."/>
        <person name="Ballif B.A."/>
        <person name="Smogorzewska A."/>
        <person name="McDonald E.R. III"/>
        <person name="Hurov K.E."/>
        <person name="Luo J."/>
        <person name="Bakalarski C.E."/>
        <person name="Zhao Z."/>
        <person name="Solimini N."/>
        <person name="Lerenthal Y."/>
        <person name="Shiloh Y."/>
        <person name="Gygi S.P."/>
        <person name="Elledge S.J."/>
      </authorList>
      <dbReference type="PubMed" id="17525332"/>
      <dbReference type="DOI" id="10.1126/science.1140321"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Embryonic kidney</tissue>
    </source>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
      <title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
      <authorList>
        <person name="Daub H."/>
        <person name="Olsen J.V."/>
        <person name="Bairlein M."/>
        <person name="Gnad F."/>
        <person name="Oppermann F.S."/>
        <person name="Korner R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Stemmann O."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="18691976"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289; SER-307; SER-309; THR-311 AND THR-780</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
      <title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
      <authorList>
        <person name="Han G."/>
        <person name="Ye M."/>
        <person name="Zhou H."/>
        <person name="Jiang X."/>
        <person name="Feng S."/>
        <person name="Jiang X."/>
        <person name="Tian R."/>
        <person name="Wan D."/>
        <person name="Zou H."/>
        <person name="Gu J."/>
      </authorList>
      <dbReference type="PubMed" id="18318008"/>
      <dbReference type="DOI" id="10.1002/pmic.200700884"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 AND SER-436</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-309; SER-360; SER-362 AND THR-780</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-275</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-309; SER-431; SER-435; SER-436 AND THR-780</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 AND SER-436</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289; THR-298; SER-307; SER-309; THR-311; SER-317; SER-431; SER-435; SER-436; THR-780 AND SER-861</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-311; SER-431; SER-435 AND SER-436</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
      <title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
      <authorList>
        <person name="Guo A."/>
        <person name="Gu H."/>
        <person name="Zhou J."/>
        <person name="Mulhern D."/>
        <person name="Wang Y."/>
        <person name="Lee K.A."/>
        <person name="Yang V."/>
        <person name="Aguiar M."/>
        <person name="Kornhauser J."/>
        <person name="Jia X."/>
        <person name="Ren J."/>
        <person name="Beausoleil S.A."/>
        <person name="Silva J.C."/>
        <person name="Vemulapalli V."/>
        <person name="Bedford M.T."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="24129315"/>
      <dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
    </citation>
    <scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-222; ARG-245; ARG-247 AND ARG-515</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
      <title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="D'Souza R.C."/>
        <person name="Yang B."/>
        <person name="Verlaan-de Vries M."/>
        <person name="Mann M."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25218447"/>
      <dbReference type="DOI" id="10.1038/nsmb.2890"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-412</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
      <title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Treffers L.W."/>
        <person name="Verlaan-de Vries M."/>
        <person name="Olsen J.V."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25772364"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-400</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
      <title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
      <authorList>
        <person name="Xiao Z."/>
        <person name="Chang J.G."/>
        <person name="Hendriks I.A."/>
        <person name="Sigurdsson J.O."/>
        <person name="Olsen J.V."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25755297"/>
      <dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-400</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-10; LYS-280; LYS-400; LYS-412; LYS-492; LYS-543; LYS-770; LYS-790; LYS-843 AND LYS-857</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="28">
    <citation type="submission" date="2007-04" db="PDB data bank">
      <title>Solution structure of the SAP domain of human splicing factor 3B subunit 2.</title>
      <authorList>
        <consortium name="RIKEN structural genomics initiative (RSGI)"/>
      </authorList>
    </citation>
    <scope>STRUCTURE BY NMR OF 24-68</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="6428" last="6428">
      <title>PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145.</title>
      <authorList>
        <person name="Yang Y."/>
        <person name="Hadjikyriacou A."/>
        <person name="Xia Z."/>
        <person name="Gayatri S."/>
        <person name="Kim D."/>
        <person name="Zurita-Lopez C."/>
        <person name="Kelly R."/>
        <person name="Guo A."/>
        <person name="Li W."/>
        <person name="Clarke S.G."/>
        <person name="Bedford M.T."/>
      </authorList>
      <dbReference type="PubMed" id="25737013"/>
      <dbReference type="DOI" id="10.1038/ncomms7428"/>
    </citation>
    <scope>METHYLATION AT ARG-508 BY PRMT9</scope>
    <scope>MUTAGENESIS OF ARG-471; ARG-495; ARG-502; ARG-508; ARG-515; ARG-530 AND ARG-537</scope>
    <scope>INTERACTION WITH SMN1</scope>
    <scope>IDENTIFICATION IN A COMPLEX WITH PRMT9; SF3B2 AND SF3B4</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="16723" last="16743">
      <title>Unique features of human protein arginine methyltransferase 9 (PRMT9) and its substrate RNA splicing factor SF3B2.</title>
      <authorList>
        <person name="Hadjikyriacou A."/>
        <person name="Yang Y."/>
        <person name="Espejo A."/>
        <person name="Bedford M.T."/>
        <person name="Clarke S.G."/>
      </authorList>
      <dbReference type="PubMed" id="25979344"/>
      <dbReference type="DOI" id="10.1074/jbc.m115.659433"/>
    </citation>
    <scope>MUTAGENESIS OF PHE-506; LYS-507; ARG-508; LYS-509 AND TYR-510</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0128558" last="E0128558">
      <title>Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.</title>
      <authorList>
        <person name="Nicolai S."/>
        <person name="Filippi S."/>
        <person name="Caputo M."/>
        <person name="Cipak L."/>
        <person name="Gregan J."/>
        <person name="Ammerer G."/>
        <person name="Frontini M."/>
        <person name="Willems D."/>
        <person name="Prantera G."/>
        <person name="Balajee A.S."/>
        <person name="Proietti-De-Santis L."/>
      </authorList>
      <dbReference type="PubMed" id="26030138"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0128558"/>
    </citation>
    <scope>INTERACTION WITH ERCC6</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2016" name="Mol. Cell" volume="64" first="307" last="319">
      <title>Molecular architecture of SF3b and structural consequences of its cancer-related mutations.</title>
      <authorList>
        <person name="Cretu C."/>
        <person name="Schmitzova J."/>
        <person name="Ponce-Salvatierra A."/>
        <person name="Dybkov O."/>
        <person name="De Laurentiis E.I."/>
        <person name="Sharma K."/>
        <person name="Will C.L."/>
        <person name="Urlaub H."/>
        <person name="Luehrmann R."/>
        <person name="Pena V."/>
      </authorList>
      <dbReference type="PubMed" id="27720643"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2016.08.036"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
    <scope>SUBUNIT</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="13573" last="13573">
      <title>Structure of the RBM7-ZCCHC8 core of the NEXT complex reveals connections to splicing factors.</title>
      <authorList>
        <person name="Falk S."/>
        <person name="Finogenova K."/>
        <person name="Melko M."/>
        <person name="Benda C."/>
        <person name="Lykke-Andersen S."/>
        <person name="Jensen T.H."/>
        <person name="Conti E."/>
      </authorList>
      <dbReference type="PubMed" id="27905398"/>
      <dbReference type="DOI" id="10.1038/ncomms13573"/>
    </citation>
    <scope>INTERACTION WITH RBM7</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2017" name="Nat. Commun." volume="8" first="15522" last="15522">
      <title>Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.</title>
      <authorList>
        <person name="Teng T."/>
        <person name="Tsai J.H."/>
        <person name="Puyang X."/>
        <person name="Seiler M."/>
        <person name="Peng S."/>
        <person name="Prajapati S."/>
        <person name="Aird D."/>
        <person name="Buonamici S."/>
        <person name="Caleb B."/>
        <person name="Chan B."/>
        <person name="Corson L."/>
        <person name="Feala J."/>
        <person name="Fekkes P."/>
        <person name="Gerard B."/>
        <person name="Karr C."/>
        <person name="Korpal M."/>
        <person name="Liu X."/>
        <person name="Lowe J.T."/>
        <person name="Mizui Y."/>
        <person name="Palacino J."/>
        <person name="Park E."/>
        <person name="Smith P.G."/>
        <person name="Subramanian V."/>
        <person name="Wu Z.J."/>
        <person name="Zou J."/>
        <person name="Yu L."/>
        <person name="Chicas A."/>
        <person name="Warmuth M."/>
        <person name="Larsen N."/>
        <person name="Zhu P."/>
      </authorList>
      <dbReference type="PubMed" id="28541300"/>
      <dbReference type="DOI" id="10.1038/ncomms15522"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference evidence="22 23 24" key="35">
    <citation type="journal article" date="2020" name="Nature" volume="583" first="310" last="313">
      <title>Molecular architecture of the human 17S U2 snRNP.</title>
      <authorList>
        <person name="Zhang Z."/>
        <person name="Will C.L."/>
        <person name="Bertram K."/>
        <person name="Dybkov O."/>
        <person name="Hartmuth K."/>
        <person name="Agafonov D.E."/>
        <person name="Hofele R."/>
        <person name="Urlaub H."/>
        <person name="Kastner B."/>
        <person name="Luehrmann R."/>
        <person name="Stark H."/>
      </authorList>
      <dbReference type="PubMed" id="32494006"/>
      <dbReference type="DOI" id="10.1038/s41586-020-2344-3"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (4.10 ANGSTROMS) IN COMPLEX WITH THE 17S U2 SNRNP COMPLEX</scope>
    <scope>FUNCTION</scope>
    <scope>IDENTIFICATION IN THE 17S U2 SNRNP COMPLEX</scope>
  </reference>
  <reference evidence="25" key="36">
    <citation type="journal article" date="2021" name="Science" volume="371">
      <title>Structure of the activated human minor spliceosome.</title>
      <authorList>
        <person name="Bai R."/>
        <person name="Wan R."/>
        <person name="Wang L."/>
        <person name="Xu K."/>
        <person name="Zhang Q."/>
        <person name="Lei J."/>
        <person name="Shi Y."/>
      </authorList>
      <dbReference type="PubMed" id="33509932"/>
      <dbReference type="DOI" id="10.1126/science.abg0879"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.89 ANGSTROMS)</scope>
    <scope>FUNCTION</scope>
    <scope>SUBUNIT</scope>
  </reference>
  <reference evidence="26" key="37">
    <citation type="journal article" date="2022" name="Science" volume="375" first="50" last="57">
      <title>Structural basis of branch site recognition by the human spliceosome.</title>
      <authorList>
        <person name="Tholen J."/>
        <person name="Razew M."/>
        <person name="Weis F."/>
        <person name="Galej W.P."/>
      </authorList>
      <dbReference type="PubMed" id="34822310"/>
      <dbReference type="DOI" id="10.1126/science.abm4245"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.30 ANGSTROMS) IN COMPLEX WITH THE 17S U2 SNRNP COMPLEX</scope>
    <scope>FUNCTION</scope>
    <scope>IDENTIFICATION IN THE 17S U2 SNRNP COMPLEX</scope>
  </reference>
  <reference evidence="27" key="38">
    <citation type="journal article" date="2023" name="Nat. Commun." volume="14" first="897" last="897">
      <title>Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly.</title>
      <authorList>
        <person name="Yang F."/>
        <person name="Bian T."/>
        <person name="Zhan X."/>
        <person name="Chen Z."/>
        <person name="Xing Z."/>
        <person name="Larsen N.A."/>
        <person name="Zhang X."/>
        <person name="Shi Y."/>
      </authorList>
      <dbReference type="PubMed" id="36797247"/>
      <dbReference type="DOI" id="10.1038/s41467-023-36489-x"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS) IN COMPLEX WITH THE 17S U2 SNRNP COMPLEX</scope>
    <scope>IDENTIFICATION IN THE 17S U2 SNRNP COMPLEX</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2021" name="Nat. Commun." volume="12" first="4680" last="4680">
      <title>Haploinsufficiency of SF3B2 causes craniofacial microsomia.</title>
      <authorList>
        <person name="Timberlake A.T."/>
        <person name="Griffin C."/>
        <person name="Heike C.L."/>
        <person name="Hing A.V."/>
        <person name="Cunningham M.L."/>
        <person name="Chitayat D."/>
        <person name="Davis M.R."/>
        <person name="Doust S.J."/>
        <person name="Drake A.F."/>
        <person name="Duenas-Roque M.M."/>
        <person name="Goldblatt J."/>
        <person name="Gustafson J.A."/>
        <person name="Hurtado-Villa P."/>
        <person name="Johns A."/>
        <person name="Karp N."/>
        <person name="Laing N.G."/>
        <person name="Magee L."/>
        <person name="Mullegama S.V."/>
        <person name="Pachajoa H."/>
        <person name="Porras-Hurtado G.L."/>
        <person name="Schnur R.E."/>
        <person name="Slee J."/>
        <person name="Singer S.L."/>
        <person name="Staffenberg D.A."/>
        <person name="Timms A.E."/>
        <person name="Wise C.A."/>
        <person name="Zarante I."/>
        <person name="Saint-Jeannet J.P."/>
        <person name="Luquetti D.V."/>
      </authorList>
      <dbReference type="PubMed" id="34344887"/>
      <dbReference type="DOI" id="10.1038/s41467-021-24852-9"/>
    </citation>
    <scope>INVOLVEMENT IN CFM1</scope>
    <scope>VARIANTS CFM1 103-GLN--PHE-895 DEL AND 638-ARG--PHE-895 DEL</scope>
  </reference>
  <comment type="function">
    <text evidence="4 6 8 13 16 17 19">Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:12234937, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:12234937, PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, SF3B2 is part of the SF3B subcomplex, which is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence in pre-mRNA (PubMed:12234937, PubMed:27720643). Sequence independent binding of SF3A and SF3B subcomplexes upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Also acts as a component of the minor spliceosome, which is involved in the splicing of U12-type introns in pre-mRNAs (PubMed:15146077, PubMed:33509932).</text>
  </comment>
  <comment type="subunit">
    <text evidence="5 6 7 8 10 12 13 14 15 16 17 19 20">Component of the 17S U2 SnRNP complex, a ribonucleoprotein complex that contains small nuclear RNA (snRNA) U2 and a number of specific proteins (PubMed:11991638, PubMed:12234937, PubMed:15146077, PubMed:32494006, PubMed:34822310, PubMed:36797247). Part of the SF3B subcomplex of the 17S U2 SnRNP complex (PubMed:12234937, PubMed:12738865, PubMed:27720643, PubMed:28541300). SF3B associates with the splicing subcomplex SF3A and a 12S RNA unit to form the U2 small nuclear ribonucleoproteins complex (U2 snRNP) (PubMed:12234937). Within the SF3B complex, interacts directly with SF3B4 (PubMed:25737013). Found in a complex with PRMT9, SF3B2 and SF3B4 (PubMed:25737013). Interacts (Arg-508-methylated form) with SMN1 (via Tudor domain) (PubMed:25737013). Interacts with RBM7 (PubMed:27905398). Interacts with ERCC6 (PubMed:26030138). Component of the minor spliceosome (PubMed:15146077, PubMed:33509932). Within this complex, interacts with SCNM1 and CRIPT (PubMed:33509932).</text>
  </comment>
  <comment type="subunit">
    <text evidence="9">(Microbial infection) Interacts with HIV-1 Vpr.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-347804">
      <id>P68400</id>
      <label>CSNK2A1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-311446">
      <id>O60231</id>
      <label>DHX16</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-348399">
      <id>P22607</id>
      <label>FGFR3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-710176">
      <id>Q70Z53</id>
      <label>FRA10AC1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-350145">
      <id>P01112</id>
      <label>HRAS</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-710124">
      <id>O60341</id>
      <label>KDM1A</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-10962083">
      <id>Q6P2P2</id>
      <label>PRMT9</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>11</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-744322">
      <id>O43395</id>
      <label>PRPF3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-538479">
      <id>Q6P2Q9</id>
      <label>PRPF8</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-746903">
      <id>Q9Y580</id>
      <label>RBM7</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-2130294">
      <id>O15541</id>
      <label>RNF113A</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-2462271">
      <id>Q15428</id>
      <label>SF3A2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-348469">
      <id>Q15427</id>
      <label>SF3B4</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>11</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-750559">
      <id>O95391</id>
      <label>SLU7</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-395421">
      <id>Q16637</id>
      <label>SMN2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-632461">
      <id>Q01081</id>
      <label>U2AF1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-295232">
      <id>Q9HCS7</id>
      <label>XAB2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-3920997">
      <id>Q96NB3</id>
      <label>ZNF830</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-749111">
      <id>Q13435</id>
    </interactant>
    <interactant intactId="EBI-25900580">
      <id>Q9Y649</id>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="13 15">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="9">Nucleus speckle</location>
    </subcellularLocation>
  </comment>
  <comment type="PTM">
    <text evidence="10">Methylation at Arg-508 by PRMT9 is required for the interaction with SMN1.</text>
  </comment>
  <comment type="disease" evidence="18">
    <disease id="DI-06354">
      <name>Craniofacial microsomia 1</name>
      <acronym>CFM1</acronym>
      <description>A form of craniofacial microsomia, a disorder characterized by a spectrum of craniofacial malformations ranging from isolated microtia with or without aural atresia to underdevelopment of the mandible, maxilla, orbit, facial soft tissue, and/or facial nerve. CFM1 is an autosomal dominant form characterized by mandibular hypoplasia, microtia, facial and preauricular skin tags, epibulbar dermoids, and lateral oral clefts. Affected individuals also present skeletal and cardiac abnormalities.</description>
      <dbReference type="MIM" id="164210"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="sequence caution" evidence="21">
    <conflict type="erroneous initiation">
      <sequence resource="EMBL-CDS" id="AAA97461" version="1"/>
    </conflict>
    <text>Truncated N-terminus.</text>
  </comment>
  <comment type="sequence caution" evidence="21">
    <conflict type="frameshift">
      <sequence resource="EMBL-CDS" id="AAA97461" version="1"/>
    </conflict>
  </comment>
  <comment type="sequence caution" evidence="21">
    <conflict type="miscellaneous discrepancy">
      <sequence resource="EMBL-CDS" id="AAH53577" version="1"/>
    </conflict>
    <text>Contaminating sequence. Potential poly-A sequence.</text>
  </comment>
  <comment type="sequence caution" evidence="21">
    <conflict type="erroneous initiation">
      <sequence resource="EMBL-CDS" id="BAG61831" version="1"/>
    </conflict>
    <text>Truncated N-terminus.</text>
  </comment>
  <dbReference type="EMBL" id="AK290850">
    <property type="protein sequence ID" value="BAF83539.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK300016">
    <property type="protein sequence ID" value="BAG61831.1"/>
    <property type="status" value="ALT_INIT"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC000401">
    <property type="protein sequence ID" value="AAH00401.2"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC007610">
    <property type="protein sequence ID" value="AAH07610.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC014125">
    <property type="protein sequence ID" value="AAH14125.2"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC053577">
    <property type="protein sequence ID" value="AAH53577.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U41371">
    <property type="protein sequence ID" value="AAA97461.1"/>
    <property type="status" value="ALT_FRAME"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS31612.1"/>
  <dbReference type="RefSeq" id="NP_006833.2">
    <property type="nucleotide sequence ID" value="NM_006842.2"/>
  </dbReference>
  <dbReference type="PDB" id="2DO5">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=24-68"/>
  </dbReference>
  <dbReference type="PDB" id="5Z56">
    <property type="method" value="EM"/>
    <property type="resolution" value="5.10 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="5Z57">
    <property type="method" value="EM"/>
    <property type="resolution" value="6.50 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="5Z58">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.90 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6AH0">
    <property type="method" value="EM"/>
    <property type="resolution" value="5.70 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6AHD">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.80 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6FF4">
    <property type="method" value="EM"/>
    <property type="resolution" value="16.00 A"/>
    <property type="chains" value="8=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6FF7">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.50 A"/>
    <property type="chains" value="8=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6QX9">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.28 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6Y50">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.10 A"/>
    <property type="chains" value="8=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6Y53">
    <property type="method" value="EM"/>
    <property type="resolution" value="7.10 A"/>
    <property type="chains" value="8=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="6Y5Q">
    <property type="method" value="EM"/>
    <property type="resolution" value="7.10 A"/>
    <property type="chains" value="8=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7ABG">
    <property type="method" value="EM"/>
    <property type="resolution" value="7.80 A"/>
    <property type="chains" value="T=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7ABH">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.50 A"/>
    <property type="chains" value="T=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7ABI">
    <property type="method" value="EM"/>
    <property type="resolution" value="8.00 A"/>
    <property type="chains" value="T=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7DVQ">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.89 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7EVO">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7ONB">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="I=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7Q3L">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="B=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7Q4O">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="B=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7Q4P">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="B=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7QTT">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="E=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="7VPX">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8CH6">
    <property type="method" value="EM"/>
    <property type="resolution" value="5.90 A"/>
    <property type="chains" value="E=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8H6E">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.20 A"/>
    <property type="chains" value="2H=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8H6J">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.25 A"/>
    <property type="chains" value="2H=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8H6K">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="2H=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8H6L">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.60 A"/>
    <property type="chains" value="2H=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8HK1">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8QO9">
    <property type="method" value="EM"/>
    <property type="resolution" value="5.29 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8QXD">
    <property type="method" value="EM"/>
    <property type="resolution" value="9.60 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8QZS">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.10 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8R08">
    <property type="method" value="EM"/>
    <property type="resolution" value="6.10 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8R09">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.30 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8R0A">
    <property type="method" value="EM"/>
    <property type="resolution" value="5.80 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8R0B">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.40 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8RM5">
    <property type="method" value="EM"/>
    <property type="resolution" value="6.90 A"/>
    <property type="chains" value="B2=1-895"/>
  </dbReference>
  <dbReference type="PDB" id="8Y7E">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.66 A"/>
    <property type="chains" value="2=1-895"/>
  </dbReference>
  <dbReference type="PDBsum" id="2DO5"/>
  <dbReference type="PDBsum" id="5Z56"/>
  <dbReference type="PDBsum" id="5Z57"/>
  <dbReference type="PDBsum" id="5Z58"/>
  <dbReference type="PDBsum" id="6AH0"/>
  <dbReference type="PDBsum" id="6AHD"/>
  <dbReference type="PDBsum" id="6FF4"/>
  <dbReference type="PDBsum" id="6FF7"/>
  <dbReference type="PDBsum" id="6QX9"/>
  <dbReference type="PDBsum" id="6Y50"/>
  <dbReference type="PDBsum" id="6Y53"/>
  <dbReference type="PDBsum" id="6Y5Q"/>
  <dbReference type="PDBsum" id="7ABG"/>
  <dbReference type="PDBsum" id="7ABH"/>
  <dbReference type="PDBsum" id="7ABI"/>
  <dbReference type="PDBsum" id="7DVQ"/>
  <dbReference type="PDBsum" id="7EVO"/>
  <dbReference type="PDBsum" id="7ONB"/>
  <dbReference type="PDBsum" id="7Q3L"/>
  <dbReference type="PDBsum" id="7Q4O"/>
  <dbReference type="PDBsum" id="7Q4P"/>
  <dbReference type="PDBsum" id="7QTT"/>
  <dbReference type="PDBsum" id="7VPX"/>
  <dbReference type="PDBsum" id="8CH6"/>
  <dbReference type="PDBsum" id="8H6E"/>
  <dbReference type="PDBsum" id="8H6J"/>
  <dbReference type="PDBsum" id="8H6K"/>
  <dbReference type="PDBsum" id="8H6L"/>
  <dbReference type="PDBsum" id="8HK1"/>
  <dbReference type="PDBsum" id="8QO9"/>
  <dbReference type="PDBsum" id="8QXD"/>
  <dbReference type="PDBsum" id="8QZS"/>
  <dbReference type="PDBsum" id="8R08"/>
  <dbReference type="PDBsum" id="8R09"/>
  <dbReference type="PDBsum" id="8R0A"/>
  <dbReference type="PDBsum" id="8R0B"/>
  <dbReference type="PDBsum" id="8RM5"/>
  <dbReference type="PDBsum" id="8Y7E"/>
  <dbReference type="AlphaFoldDB" id="Q13435"/>
  <dbReference type="EMDB" id="EMD-10688"/>
  <dbReference type="EMDB" id="EMD-10689"/>
  <dbReference type="EMDB" id="EMD-11695"/>
  <dbReference type="EMDB" id="EMD-11696"/>
  <dbReference type="EMDB" id="EMD-11697"/>
  <dbReference type="EMDB" id="EMD-12994"/>
  <dbReference type="EMDB" id="EMD-13793"/>
  <dbReference type="EMDB" id="EMD-13811"/>
  <dbReference type="EMDB" id="EMD-13812"/>
  <dbReference type="EMDB" id="EMD-14146"/>
  <dbReference type="EMDB" id="EMD-16658"/>
  <dbReference type="EMDB" id="EMD-18529"/>
  <dbReference type="EMDB" id="EMD-18718"/>
  <dbReference type="EMDB" id="EMD-18781"/>
  <dbReference type="EMDB" id="EMD-18786"/>
  <dbReference type="EMDB" id="EMD-18787"/>
  <dbReference type="EMDB" id="EMD-18788"/>
  <dbReference type="EMDB" id="EMD-18789"/>
  <dbReference type="EMDB" id="EMD-19349"/>
  <dbReference type="EMDB" id="EMD-30875"/>
  <dbReference type="EMDB" id="EMD-31334"/>
  <dbReference type="EMDB" id="EMD-32074"/>
  <dbReference type="EMDB" id="EMD-34500"/>
  <dbReference type="EMDB" id="EMD-34505"/>
  <dbReference type="EMDB" id="EMD-34507"/>
  <dbReference type="EMDB" id="EMD-34508"/>
  <dbReference type="EMDB" id="EMD-34841"/>
  <dbReference type="EMDB" id="EMD-39013"/>
  <dbReference type="EMDB" id="EMD-4255"/>
  <dbReference type="EMDB" id="EMD-4665"/>
  <dbReference type="EMDB" id="EMD-6889"/>
  <dbReference type="EMDB" id="EMD-6890"/>
  <dbReference type="EMDB" id="EMD-6891"/>
  <dbReference type="EMDB" id="EMD-9621"/>
  <dbReference type="EMDB" id="EMD-9624"/>
  <dbReference type="SMR" id="Q13435"/>
  <dbReference type="BioGRID" id="116188">
    <property type="interactions" value="524"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-2227">
    <property type="entry name" value="SF3B complex"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-2539">
    <property type="entry name" value="U2 small nuclear ribonucleoprotein complex"/>
  </dbReference>
  <dbReference type="CORUM" id="Q13435"/>
  <dbReference type="IntAct" id="Q13435">
    <property type="interactions" value="191"/>
  </dbReference>
  <dbReference type="MINT" id="Q13435"/>
  <dbReference type="STRING" id="9606.ENSP00000318861"/>
  <dbReference type="ChEMBL" id="CHEMBL1229011"/>
  <dbReference type="GlyGen" id="Q13435">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q13435"/>
  <dbReference type="MetOSite" id="Q13435"/>
  <dbReference type="PhosphoSitePlus" id="Q13435"/>
  <dbReference type="SwissPalm" id="Q13435"/>
  <dbReference type="BioMuta" id="SF3B2"/>
  <dbReference type="DMDM" id="296452908"/>
  <dbReference type="jPOST" id="Q13435"/>
  <dbReference type="MassIVE" id="Q13435"/>
  <dbReference type="PaxDb" id="9606-ENSP00000318861"/>
  <dbReference type="PeptideAtlas" id="Q13435"/>
  <dbReference type="ProteomicsDB" id="59431"/>
  <dbReference type="Pumba" id="Q13435"/>
  <dbReference type="TopDownProteomics" id="Q13435"/>
  <dbReference type="Antibodypedia" id="30058">
    <property type="antibodies" value="253 antibodies from 27 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="10992"/>
  <dbReference type="Ensembl" id="ENST00000322535.11">
    <property type="protein sequence ID" value="ENSP00000318861.6"/>
    <property type="gene ID" value="ENSG00000087365.16"/>
  </dbReference>
  <dbReference type="GeneID" id="10992"/>
  <dbReference type="KEGG" id="hsa:10992"/>
  <dbReference type="MANE-Select" id="ENST00000322535.11">
    <property type="protein sequence ID" value="ENSP00000318861.6"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_006842.3"/>
    <property type="RefSeq protein sequence ID" value="NP_006833.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001ogy.2">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:10769"/>
  <dbReference type="CTD" id="10992"/>
  <dbReference type="DisGeNET" id="10992"/>
  <dbReference type="GeneCards" id="SF3B2"/>
  <dbReference type="HGNC" id="HGNC:10769">
    <property type="gene designation" value="SF3B2"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000087365">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="SF3B2"/>
  <dbReference type="MIM" id="164210">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="605591">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q13435"/>
  <dbReference type="OpenTargets" id="ENSG00000087365"/>
  <dbReference type="PharmGKB" id="PA35687"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000087365"/>
  <dbReference type="eggNOG" id="KOG2330">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00390000006734"/>
  <dbReference type="InParanoid" id="Q13435"/>
  <dbReference type="OMA" id="KGEPIGQ"/>
  <dbReference type="OrthoDB" id="5476818at2759"/>
  <dbReference type="PhylomeDB" id="Q13435"/>
  <dbReference type="TreeFam" id="TF300635"/>
  <dbReference type="PathwayCommons" id="Q13435"/>
  <dbReference type="Reactome" id="R-HSA-72163">
    <property type="pathway name" value="mRNA Splicing - Major Pathway"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-72165">
    <property type="pathway name" value="mRNA Splicing - Minor Pathway"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q13435"/>
  <dbReference type="SIGNOR" id="Q13435"/>
  <dbReference type="BioGRID-ORCS" id="10992">
    <property type="hits" value="789 hits in 1166 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="SF3B2">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q13435"/>
  <dbReference type="GeneWiki" id="SF3B2"/>
  <dbReference type="GenomeRNAi" id="10992"/>
  <dbReference type="Pharos" id="Q13435">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q13435"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 11"/>
  </dbReference>
  <dbReference type="RNAct" id="Q13435">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000087365">
    <property type="expression patterns" value="Expressed in ventricular zone and 201 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q13435">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071013">
    <property type="term" value="C:catalytic step 2 spliceosome"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016607">
    <property type="term" value="C:nuclear speck"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071011">
    <property type="term" value="C:precatalytic spliceosome"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005681">
    <property type="term" value="C:spliceosomal complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005689">
    <property type="term" value="C:U12-type spliceosomal complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005686">
    <property type="term" value="C:U2 snRNP"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071005">
    <property type="term" value="C:U2-type precatalytic spliceosome"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005684">
    <property type="term" value="C:U2-type spliceosomal complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006397">
    <property type="term" value="P:mRNA processing"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000398">
    <property type="term" value="P:mRNA splicing, via spliceosome"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008380">
    <property type="term" value="P:RNA splicing"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:1903241">
    <property type="term" value="P:U2-type prespliceosome assembly"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="ComplexPortal"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR007180">
    <property type="entry name" value="DUF382"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR006568">
    <property type="entry name" value="PSP_pro-rich"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR003034">
    <property type="entry name" value="SAP_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR052584">
    <property type="entry name" value="U2_snRNP_Complex_Component"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR12785">
    <property type="entry name" value="SPLICING FACTOR 3B"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR12785:SF6">
    <property type="entry name" value="SPLICING FACTOR 3B SUBUNIT 2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF04037">
    <property type="entry name" value="DUF382"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF04046">
    <property type="entry name" value="PSP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02037">
    <property type="entry name" value="SAP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00581">
    <property type="entry name" value="PSP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00513">
    <property type="entry name" value="SAP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50800">
    <property type="entry name" value="SAP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0175">Coiled coil</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <keyword id="KW-0507">mRNA processing</keyword>
  <keyword id="KW-0508">mRNA splicing</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0747">Spliceosome</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="chain" id="PRO_0000174328" description="Splicing factor 3B subunit 2">
    <location>
      <begin position="1"/>
      <end position="895"/>
    </location>
  </feature>
  <feature type="domain" description="SAP" evidence="2">
    <location>
      <begin position="24"/>
      <end position="58"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="1"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="65"/>
      <end position="136"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="197"/>
      <end position="373"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="400"/>
      <end position="453"/>
    </location>
  </feature>
  <feature type="region of interest" description="Required for interaction with PRMT9" evidence="10">
    <location>
      <begin position="401"/>
      <end position="550"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="691"/>
      <end position="757"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="844"/>
      <end position="895"/>
    </location>
  </feature>
  <feature type="coiled-coil region" evidence="1">
    <location>
      <begin position="140"/>
      <end position="199"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Pro residues" evidence="3">
    <location>
      <begin position="10"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Pro residues" evidence="3">
    <location>
      <begin position="84"/>
      <end position="136"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Pro residues" evidence="3">
    <location>
      <begin position="225"/>
      <end position="251"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="278"/>
      <end position="300"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic residues" evidence="3">
    <location>
      <begin position="322"/>
      <end position="338"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="344"/>
      <end position="359"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="400"/>
      <end position="429"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="695"/>
      <end position="712"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="3">
    <location>
      <begin position="713"/>
      <end position="732"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="37">
    <location>
      <position position="222"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="37">
    <location>
      <position position="245"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="37">
    <location>
      <position position="247"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="32">
    <location>
      <position position="275"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="29 31 36">
    <location>
      <position position="289"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="36">
    <location>
      <position position="298"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="31 33 34 36">
    <location>
      <position position="307"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="31 33 34 36">
    <location>
      <position position="309"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="31 36 38">
    <location>
      <position position="311"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="36">
    <location>
      <position position="317"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="33">
    <location>
      <position position="360"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="33">
    <location>
      <position position="362"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="28 30 34 35 36 38">
    <location>
      <position position="431"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="28 30 34 35 36 38">
    <location>
      <position position="435"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="28 30 34 35 36 38">
    <location>
      <position position="436"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; by PRMT9; alternate" evidence="10">
    <location>
      <position position="508"/>
    </location>
  </feature>
  <feature type="modified residue" description="Symmetric dimethylarginine; by PRMT9; alternate" evidence="10">
    <location>
      <position position="508"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="37">
    <location>
      <position position="515"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="31 33 34 36">
    <location>
      <position position="780"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="36">
    <location>
      <position position="861"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="10"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="280"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="40 41 42">
    <location>
      <position position="400"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="39 42">
    <location>
      <position position="412"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="492"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="543"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="770"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="790"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="843"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="42">
    <location>
      <position position="857"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_087086" description="In CFM1." evidence="18">
    <location>
      <begin position="103"/>
      <end position="895"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_087087" description="In CFM1." evidence="18">
    <location>
      <begin position="638"/>
      <end position="895"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="10">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="471"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="10">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="495"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="10">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="502"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9; when associated with A-510." evidence="11">
    <original>F</original>
    <variation>A</variation>
    <location>
      <position position="506"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with A-509." evidence="11">
    <original>K</original>
    <variation>A</variation>
    <location>
      <position position="507"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with R-509. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-508. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with K-508 and R-509." evidence="11">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="507"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes interaction with SMN1; Abolishes methylation by PRMT9. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507 and R-509." evidence="10 11">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="508"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with A-507." evidence="10">
    <original>K</original>
    <variation>A</variation>
    <location>
      <position position="509"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with K-508 and R-507." evidence="10">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="509"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9; when associated with A-506." evidence="11">
    <original>Y</original>
    <variation>A</variation>
    <location>
      <position position="510"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="10">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="515"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="10">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="530"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="10">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="537"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; BAF83539." evidence="21" ref="1">
    <original>K</original>
    <variation>E</variation>
    <location>
      <position position="602"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; BAF83539." evidence="21" ref="1">
    <original>E</original>
    <variation>G</variation>
    <location>
      <position position="765"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="29"/>
      <end position="39"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="47"/>
      <end position="61"/>
    </location>
  </feature>
  <feature type="helix" evidence="47">
    <location>
      <begin position="454"/>
      <end position="457"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="462"/>
      <end position="468"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="472"/>
      <end position="474"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="479"/>
      <end position="481"/>
    </location>
  </feature>
  <feature type="strand" evidence="48">
    <location>
      <begin position="482"/>
      <end position="484"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="485"/>
      <end position="493"/>
    </location>
  </feature>
  <feature type="strand" evidence="45">
    <location>
      <begin position="494"/>
      <end position="496"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="502"/>
      <end position="505"/>
    </location>
  </feature>
  <feature type="turn" evidence="48">
    <location>
      <begin position="510"/>
      <end position="513"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="514"/>
      <end position="518"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="526"/>
      <end position="529"/>
    </location>
  </feature>
  <feature type="turn" evidence="48">
    <location>
      <begin position="530"/>
      <end position="532"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="533"/>
      <end position="536"/>
    </location>
  </feature>
  <feature type="turn" evidence="44">
    <location>
      <begin position="544"/>
      <end position="546"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="549"/>
      <end position="554"/>
    </location>
  </feature>
  <feature type="turn" evidence="44">
    <location>
      <begin position="555"/>
      <end position="557"/>
    </location>
  </feature>
  <feature type="helix" evidence="48">
    <location>
      <begin position="568"/>
      <end position="576"/>
    </location>
  </feature>
  <feature type="turn" evidence="48">
    <location>
      <begin position="593"/>
      <end position="597"/>
    </location>
  </feature>
  <feature type="helix" evidence="45">
    <location>
      <begin position="611"/>
      <end position="617"/>
    </location>
  </feature>
  <feature type="strand" evidence="45">
    <location>
      <begin position="624"/>
      <end position="626"/>
    </location>
  </feature>
  <feature type="helix" evidence="45">
    <location>
      <begin position="633"/>
      <end position="639"/>
    </location>
  </feature>
  <feature type="turn" evidence="45">
    <location>
      <begin position="652"/>
      <end position="654"/>
    </location>
  </feature>
  <feature type="turn" evidence="46">
    <location>
      <begin position="657"/>
      <end position="659"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="692"/>
      <end position="702"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1"/>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00186"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="3">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="10882114"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="11991638"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="12234937"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="12738865"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="15146077"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="16923959"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="25737013"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="25979344"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="26030138"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="27720643"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="27905398"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="28541300"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="32494006"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="33509932"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="34344887"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="34822310"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="36797247"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="21"/>
  <evidence type="ECO:0007744" key="22">
    <source>
      <dbReference type="PDB" id="6Y50"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="23">
    <source>
      <dbReference type="PDB" id="6Y53"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="24">
    <source>
      <dbReference type="PDB" id="6Y5Q"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="25">
    <source>
      <dbReference type="PDB" id="7DVQ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="26">
    <source>
      <dbReference type="PDB" id="7Q3L"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="27">
    <source>
      <dbReference type="PDB" id="8HK1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PubMed" id="17081983"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="29">
    <source>
      <dbReference type="PubMed" id="17525332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="30">
    <source>
      <dbReference type="PubMed" id="18318008"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="34">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="35">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="36">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="37">
    <source>
      <dbReference type="PubMed" id="24129315"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="38">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="39">
    <source>
      <dbReference type="PubMed" id="25218447"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="40">
    <source>
      <dbReference type="PubMed" id="25755297"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="41">
    <source>
      <dbReference type="PubMed" id="25772364"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="42">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="43">
    <source>
      <dbReference type="PDB" id="2DO5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="44">
    <source>
      <dbReference type="PDB" id="7DVQ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="45">
    <source>
      <dbReference type="PDB" id="7EVO"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="46">
    <source>
      <dbReference type="PDB" id="7ONB"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="47">
    <source>
      <dbReference type="PDB" id="7Q3L"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="48">
    <source>
      <dbReference type="PDB" id="7Q4O"/>
    </source>
  </evidence>
  <sequence length="895" mass="100228" checksum="D372AFA679443AD6" modified="2010-05-18" version="2">MATEHPEPPKAELQLPPPPPPGHYGAWAAQELQAKLAEIGAPIQGNREELVERLQSYTRQTGIVLNRPVLRGEDGDKAAPPPMSAQLPGIPMPPPPLGLPPLQPPPPPPPPPPGLGLGFPMAHPPNLGPPPPLRVGEPVALSEEERLKLAQQQAALLMQQEERAKQQGDHSLKEHELLEQQKRAAVLLEQERQQEIAKMGTPVPRPPQDMGQIGVRTPLGPRVAAPVGPVGPTPTVLPMGAPVPRPRGPPPPPGDENREMDDPSVGPKIPQALEKILQLKESRQEEMNSQQEEEEMETDARSSLGQSASETEEDTVSVSKKEKNRKRRNRKKKKKPQRVRGVSSESSGDREKDSTRSRGSDSPAADVEIEYVTEEPEIYEPNFIFFKRIFEAFKLTDDVKKEKEKEPEKLDKLENSAAPKKKGFEEEHKDSDDDSSDDEQEKKPEAPKLSKKKLRRMNRFTVAELKQLVARPDVVEMHDVTAQDPKLLVHLKATRNSVPVPRHWCFKRKYLQGKRGIEKPPFELPDFIKRTGIQEMREALQEKEEQKTMKSKMREKVRPKMGKIDIDYQKLHDAFFKWQTKPKLTIHGDLYYEGKEFETRLKEKKPGDLSDELRISLGMPVGPNAHKVPPPWLIAMQRYGPPPSYPNLKIPGLNSPIPESCSFGYHAGGWGKPPVDETGKPLYGDVFGTNAAEFQTKTEEEEIDRTPWGELEPSDEESSEEEEEEESDEDKPDETGFITPADSGLITPGGFSSVPAGMETPELIELRKKKIEEAMDGSETPQLFTVLPEKRTATVGGAMMGSTHIYDMSTVMSRKGPAPELQGVEVALAPEELELDPMAMTQKYEEHVREQQAQVEKEDFSDMVAEHAAKQKQKKRKAQPQDSRGGSKKYKEFKF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>